Emerging issues in pharmacological management of rheumatoid arthritis: Results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations

Journal of Rheumatology

Volumn 39, Issue 8, 2012, Pages 1555-1558

  Bykerk, Vivian P ^a,b,c,g   Schieir, Orit ^a,d,e,g   Akhavan, Pooneh ^a,c,g   Hazlewood, Glen S ^a,c,g   Cheng, Carly K ^a,c,g   Bombardier, Claire ^a,c,d,f,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b HARVARD UNIVERSITY   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f Division of Clinical Decision Making and Health Care   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antirheumatic agents; Physician practice patterns; Rheumatoid arthritis

Indexed keywords

ABATACEPT; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; BIOLOGICAL THERAPY; CANADA; CLINICAL PRACTICE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG MECHANISM; FEMALE; HEALTH SURVEY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HEALTH CARE SURVEYS; HUMANS; NEEDS ASSESSMENT; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RHEUMATOLOGY;

EID: 84864546733     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110208     Document Type: Article

References (7)

1. O'Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med 2004;350:2591-602.
2. Knevel R, Schoels M, Huizinga TW, Aletaha D, Burmester GR, Combe B, et al. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010;69:987-94.
3. Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res 2010;62:647-56.
4. Davis D, Goldman J, Palda VA. Canadian Medical Association handbook on clinical practice guidelines; 2007. [Internet; accessed Aug 18, 2011]. Available from: www.cma.ca/multimedia/CMA/content-images/ClinicalResources/PDF/English/ CPGHandbook.pdf
5. Harrison MB, Legare F, Graham ID, Fervers B. Adapting clinical practice guidelines to local context and assessing barriers to their use. CMAJ 2010;182:E78-84.
6. Bykerk V, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2011;38:1559-82.
7. Bombardier C, Akhavan P, Hazlewood G, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: Part II Safety. J Rheumatol 2011; (submitted).